The transactivation potential of variant hepatocyte nuclear factor 1 is modified by alternative splicing.

J Biol Chem

Unité des Virus Oncogènes, UA 1644 du CNRS, Département des Biotechnologies, Institut Pasteur, Paris, France.

Published: December 1993

Two forms of the transcription factor vHNF1 (HNF1 beta or LFB3) have been previously described, derived by alternative splicing from a common premessenger RNA, and have been called vHNF1-A and vHNF1-B. vHNF1 proteins share a homologous homeo-related DNA-binding domain with the HNF1 protein, initially characterized as a liver-restricted transcription factor, and bind to a similar sequence motif. Here we demonstrate that vHNF1-A is a stronger transactivator than vHNF1-B when assayed in transient transfections using two different promoters. vHNF1-A also binds DNA with a higher affinity suggesting that a region of the protein located immediately upstream of the homeodomain can modulate the protein/DNA interaction and transactivation. Both vHNF1 transcripts were found at a constant ratio in every tissue where vHNF1 expression could be detected, using a quantitative reverse transcriptase-polymerase chain reaction.

Download full-text PDF

Source

Publication Analysis

Top Keywords

alternative splicing
8
transcription factor
8
transactivation potential
4
potential variant
4
variant hepatocyte
4
hepatocyte nuclear
4
nuclear factor
4
factor modified
4
modified alternative
4
splicing forms
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!